Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer

BACKGROUND: Single agent immune checkpoint inhibitors (ICIs) improve survival outcomes compared to chemotherapy for advanced non‐small cell lung cancer (NSCLC), but treatment efficacy widely varies. The combination of ICIs with chemotherapy has shown promising efficacy over chemotherapy alone; howev...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Thorac Cancer
Главные авторы: Kuo, Chih‐Hsi Scott, Wang, Chin‐Chou, Huang, Yu‐Chen, Pavlidis, Stelios, Liu, Chien‐Ying, Ko, How‐Wen, Chung, Fu‐Tsai, Lin, Tin‐Yu, Wang, Chih‐Liang, Guo, Yi‐Ke, Yang, Cheng‐Ta
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons Australia, Ltd 2019
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501017/
https://ncbi.nlm.nih.gov/pubmed/30950239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13057
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы